Supplements and Featured Publications
Balancing Therapeutic Safety and Efficacy to Improve Clinical and Economic Outcomes in Schizophrenia
Volume: 20
Issue: 8 Suppl
Improving Clinical and Managed Care Outcomes in Rheumatoid Arthritis: New Guidelines, Therapies, and
Volume: 20
Issue: 7 Suppl
Clinical Trial Designs in PAH: Shifting From Functional Measurements to Long-term Clinical Outco
Volume: 20
Issue: 6 Suppl
Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imagi
Volume: 20
Issue: 5 Suppl
Improving Transitions of Care for Patients With Thromboembolic Disease
Volume: 20
Issue: 4 Suppl
Practical Perspectives on the Management of Overweight and Obesity
Volume: 20
Issue: 3 Suppl
Evolving Strategies for the Management of Multiple Myeloma: A Managed Care Perspective
Volume: 20
Issue: 2 Suppl
Opportunities for Improving Attainment of Quality Measures in Patients With Type 2 Diabetes Mellitus
Volume: 20
Issue: 1 Suppl
Reducing the Impact of Unintended Pregnancies (UIPs) on the US Health System
Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molec
Volume: 19
Issue: 19 Suppl
Castration-Resistant Prostate Cancer: Addressing Treatment Challenges, Managed Care Aspects, and Int
Volume: 19
Issue: 18 Suppl
Special Report: Diabetes Innovation 2013
Current Topics in Multiple Sclerosis
Volume: 19
Issue: 17 Suppl
A Data-Driven Approach to Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CNE/CP
Volume: 19
Issue: 16 Suppl
Translating Clinical Guidelines Into Practice: The Effective and Appropriate Use of Human Growth Hor
Volume: 19
Issue: 15 Suppl
NSAIDs: Optimizing Pain Management Through Risk Reduction
Volume: 19
Issue: 14 Suppl
Management of Patients with Homozygous Familial Hypercholesterolemia
Volume: 19
Issue: 13 Suppl
Addressing Adherence Challenges Associated With Antiretroviral Therapy: Focus on Noninfectious Diarr
Volume: 19
Issue: 12 Suppl
The Clinical and Economic Consequences of Obesity
Volume: 19
Issue: 11 Suppl
The Quality Enterprise—What Is It, Where Is It Going, and How Will It Be Impacted by Healthcare Reform?
Volume: 19
Issue: 9 Suppl
The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Pa
Volume: 19
Issue: 10 Suppl
Pathways to Success: Utilizing Managed Care Models to Improve Clinical and Economic Outcomes in Diab
Volume: 19
Issue: 8 Suppl
Hereditary Angioedema: Facilitating Diagnosis and Optimizing Clinical and Economic Outcomes [CPE/CME
Volume: 19
Issue: 7 Suppl
Value-Based Insurance Design: Perspectives, Extending the Evidence, and Implications for the Future
The Economic Impact of Medicare Part D on Congestive Heart Failure
Volume: 19
Issue: 6 Suppl
![Addressing the Clinical and Managed Care Challenges in Treating Diseases of the Aging Eye [CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/4ad1f4047a64cc2f0f60d8e454804f78c24e866c-879x1200.png?w=230&fit=crop&auto=format)
Addressing the Clinical and Managed Care Challenges in Treating Diseases of the Aging Eye [CPE]
Volume: 19
Issue: 5 Suppl
The Clinical and Psychosocial Impact of Peyronie’s Disease
Volume: 19
Issue: 4 Suppl
Managing Costs in High-Risk Obstetrics
Type 2 Diabetes and the Evolving Paradigm in Glucose Regulation
Volume: 19
Issue: 3 Suppl
![Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/6594629bd041f089213fa76b19562bda6baeb63d-300x409.jpg?w=230&fit=crop&auto=format)
Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CPE]
Volume: 19
Issue: 2 Suppl
Advertisement
Advertisement
Trending on AJMC
1
J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort
2
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
3
Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data
4
Postpandemic Nursing Home Capacity Declines Tied to Longer Hospital Stays, Increased Patient Travel
5
